Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers http://novacyt.com/wp-content/uploads/2019/03/Contrat-de-liquidité-1-mars-2019.pdf
Visit PageCategory: Board
Liquidity Agreement Monthly Update and Total Voting Rights
Paris, France and Camberley, UK – 1 March 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, today announces its monthly update in relation to ordinary shares traded under its ongoing liquidity agreement with Invest Securities SA (the “Liquidity Agreement”). The Liquidity Agreement is governed by French law and is further summarised
Visit PageFunding update
Funding update Paris, France and Camberley, UK – 26 February 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces an update on its current position and funding plans. The Company confirms that 2019 trading has started positively and is in line with 2019 management expectations. The Company also continues
Visit Page